<
News / Press release
Recall of eight batches of two products of Apo-Hydroxyzine Capsules
Hong Kong, 13 May 2026.
The Department of Health (DH) today (13 May) endorsed a licensed drug wholesaler, Hind Wing Company Limited (Hind Wing), to recall one batch (batch number: AW6448A) of the product, namely Apo-Hydroxyzine Cap 10mg (Hong Kong Registration number: HK-39891) and seven batches (batch numbers: AW5758A, AW6084A, AW7380A, AW7456A, AW7457A, AW8516A and AW8647A) of product, namely Apo-Hydroxyzine Cap 25mg (Hong Kong Registration number: HK-43483) from the market because the products were supplied with incorrect shelf-life.The DH received notification from Hind Wing that the overseas manufacturer of the products is recalling the above batches of Apo-Hydroxyzine Capsules from the market because of the products were labelled with a shelf-life longer than the approved shelf-life. Hind Wing therefore is voluntarily recalling the affected batches from the market.
The above two products both contain hydroxyzine in different strengths which are prescription medicines used for the management of anxiety, allergic itch, premedication before surgical procedures, and control of nausea and vomiting. According to Hind Wing, the affected batches had been imported into Hong Kong and supplied to private doctors, private hospitals and pharmacies, and exported to Macao.
Hind Wing has set up a hotline 2541 5731 to answer related enquiries.
So far, Hind Wing has not received any adverse reaction reports in connection with the products.
Patients should not stop taking the products without talking to your doctors. If in doubt, please consult the healthcare professionals immediately.
Ends/ Wednesday, May 13, 2026
Voluntary Precautionary Recall of Apo- Fluoxetine Capsules 20mg
Hong Kong, 10 Apr 2026.
The Department of Health (DH) (April 10) endorsed Hind Wing Company Limited (Hind Wing), to recall one batch (batch number: VM4608) of Apo-Fluoxetine Capsules 20mg (Hong Kong registration number: HK-68820), from the market as a precautionary measure due to a potential quality issue.The overseas manufacturer of the product is recalling the above batch due to out of trend degradation product test results. As a precautionary measure, Hind Wing is voluntarily recalling the affected batch from the market.
The above product, containing fluoxetine, is a prescription medicine used for the treatment of depression.
The affected batch has been imported into Hong Kong and supplied to private hospitals, private doctors and pharmacies.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Friday, April 10, 2026
Voluntary Precautionary Recall of Apo-Amitriptyline Tablets 10mg & 25mg
Hong Kong, 18 Oct 2024.
The Department of Health (DH) endorsed Hind Wing Co Ltd (Hind Wing) on 18 October 2024, to recall batches of the following product from the market as a precautionary measure due to the potential presence of an impurity (N-Nitrosonortriptyline (NNORT)) in the products.The manufacturer is extending the recall to additional lots out of an abundance of caution only.
To date, there are no relevant adverse event reports or complaints received for below lots.
| Name of product | Hong Kong registration number | Batch number |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | TF8589 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | TF8587 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | RR0266 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | RV1644 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | RW8597 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | TA6008 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | RN6384 |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | TF8585 |
| Apo-Amitriptyline Tablets 25mg | HK-09274 | RM8130 |
| Apo-Amitriptyline Tablets 25mg | HK-09274 | RR0781 |
| Apo-Amitriptyline Tablets 25mg | HK-09274 | RV1656 |
| Apo-Amitriptyline Tablets 25mg | HK-09274 | RW8691 |
| Apo-Amitriptyline Tablets 25mg | HK-09274 | TA6062 |
| Apo-Amitriptyline Tablets 25mg | HK-09274 | TF8602 |
The above affected batch of the product have been imported into Hong Kong and supplied to local doctors, pharmacies, DH clinics, private hospitals and reexported to Macau.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Friday, October 18, 2024
Recall of Apo-Mometasone 50mcg Nasal Spray
Hong Kong, 16 Feb 2024.
The Department of Health (DH) today (Feb 16th) endorsed Hind Wing Co Ltd (Hind Wing), to recall one batch of Apo-Mometasone Nasal Spray from the market as a precautionary measure due to the potential presence of Burkholderia cepacia complex.This recall is being initiated out of an abundance of caution and as a precautionary measure only as there is currently no microbiological testing failure (BCC) observed in any of the product batches that are within shelf-life in the market.
| Name of product | Hong Kong registration number | Batch number | Expiry date |
| Apo-Mometasone 50mcg Nasal Spray | HK-62898 | TX5343 | 2025/09 |
The above affected batches of the products have been imported into Hong Kong and supplied to local doctors, pharmacies and HA
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Friday, Feb 16th, 2024.
Recall of Apo-Acyclovir Tablets 200mg, 400mg and 800mg
[Hong Kong, 14 Aug 2023] The Department of Health (DH) today (August 14) endorsed Hind Wing Co Ltd (Hind Wing), to recall a total of three batches of the following three products from the market as a precautionary measure due to the presence of an impurity (N-nitrosodimethylamine(NDMA)) in the products.| Name of product | Hong Kong registration number | Batch number | Expiry date |
| Apo-Acyclovir Tablets 200mg | HK-43427 | TK5832 | 2025/05 |
| Apo-Acyclovir Tablets 400mg | HK-58229 | TH6096 | 2023/12 |
| Apo-Acyclovir Tablets 800mg | HK-58228 | TK1734 | 2024/05 |
The above affected batches of the products have been imported into Hong Kong and supplied to local doctors, pharmacies and DH clinics.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Monday, August 14, 2023
Voluntary Precautionary Recall of Apo-Amitriptyline Tablets 10mg
[Hong Kong, 14 August 2023] The Department of Health (DH) endorsed Hind Wing Co Ltd (Hind Wing) on 14 August 2023, to recall a batch of the following product from the market as a precautionary measure due to the presence of an impurity (N-Nitrosonortriptyline (NNORT)) in the products.Per the information provided from the manufacturer, due to a defective filter, some extractable substances may be above the acceptable limit. As a precautionary measure, the affected batches are recalled on a precautionary basis.
| Name of product | Hong Kong registration number | Batch number |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | RM0518 |
The above affected batch of the product have been imported into Hong Kong and supplied to local doctors, pharmacies, DH clinics, HA hospitals, private hospitals and reexported to Macau.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Monday, August 14, 2023
Manufacturer Address :150 SIGNET DRIVE WESTON ONTARIO CANADA M9L 1T9
Voluntary Precautionary recall of HALOPERIDOL-NEURAXPHARM DECANOATE SOLUTION FOR INJECTION 50MG/ML under HK-65059 and HALOPERIDOL-NEURAXPHARM DECANOATE SOLUTION FOR INJECTION 100MG/ML under HK-65060
[Hong Kong 24 March 2023] The Department of Health (DH) Today (March 24th) endorsed Hind Wing Co Ltd (HW), a licensed wholesaler to conduct a voluntary recall of six batches of below two products as a precautionary measure.Per the information provided from the manufacturer, due to a defective filter, some extractable substances may be above the acceptable limit. As a precautionary measure, the affected batches are recalled on a precautionary basis.
| Name of product | HK Registration # | Batch number | Expiry Date |
| HALOPERIDOL-NEURAXPHARM DECANOATE SOLUTION FOR INJECTION 50MG/ML | HK-65059 | 190416 | 2023/02 |
| 191221 | 2023/02 | ||
| 200176 | 2024/02 | ||
| 210247 | 2024/11 | ||
| 210656 | 2024/12 | ||
| HALOPERIDOL-NEURAXPHARM DECANOATE SOLUTION FOR INJECTION 100MG/ML | HK-65060 | 200178 | 2024/02 |
The above batches have been supplied to HA and local doctors and propose recall is up to Hospital and doctor level only.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Monday, March 24, 2023
Voluntary Precautionary Recall of Apo-Amitriptyline Tablets 10mg
[Hong Kong, 03 February 2023] The Department of Health (DH) endorsed Hind Wing Co Ltd (Hind Wing) on 03 February 2023, to recall a batch of the following product from the market as a precautionary measure due to the presence of an impurity (N-nitrosodimethylamine (NDMA)) in the products.| Name of product | Hong Kong registration number | Batch number |
| Apo-Amitriptyline Tablets 10mg | HK-09273 | PY1904 |
The above affected batch of the product have been imported into Hong Kong and supplied to local doctors, pharmacies, DH clinics, private hospitals and reexported to Macau.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Friday, February 03, 2023
Manufacturer Address :150 SIGNET DRIVE WESTON ONTARIO CANADA M9L 1T9
Voluntary Precautionary recall of Fluphenazin-Neuraxpharm D Solution for injection 25mg/ml under HK-64620, batch 202052, exp 2024/01.
The Department of Health (DH) Today (December 1st) endorsed Hind Wing Co Ltd (HW), a licensed wholesaler to conduct a voluntary recall of one batch of below product as a precautionary measure due to higher value of polypropylene additives and Irganox shown during re-validation of the filter cartridges used in past productions, as informed by the overseas manufacturer.| Name of product | HK Registration # | Batch number |
| FLUPHENAZIN-NEURAXPHARM D SOLUTION FOR INJECTION 25MG/ML | HK-64620 | 202052 |
The above batches have been supplied to local doctors, pharmacies and HA.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Thursday, December 1, 2022
Recall of Apo-Acyclovir Tablets 200mg and 800mg
[Hong Kong, 29 July 2022] The Department of Health (DH) today (July 29) endorsed Hind Wing Co Ltd (Hind Wing), to recall a total of three batches of the following two products from the market as a precautionary measure due to the presence of an impurity (N-nitrosodimethylamine) in the products.| Name of product | Hong Kong registration number | Batch number |
| Apo-Acyclovir Tablets 200mg | HK-43427 | TF4466 |
| Apo-Acyclovir Tablets 800mg | HK-58228 | TE5062 TH6119 |
The above affected batches of the products have been imported into Hong Kong and supplied to local doctors, pharmacies and DH clinics.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Friday, July 29, 2022